---
title: "Winning Health Technology Group Co.,Ltd. (300253.SZ)"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/300253.SZ.md"
symbol: "300253.SZ"
name: "Winning Health Technology Group Co.,Ltd."
industry: "Health Care Technology"
datetime: "2026-03-13T09:42:13.593Z"
locales:
  - [en](https://longbridge.com/en/quote/300253.SZ.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/300253.SZ.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/300253.SZ.md)
---

> Supported Languages: [简体中文](https://longbridge.com/zh-CN/quote/300253.SZ.md) | [繁體中文](https://longbridge.com/zh-HK/quote/300253.SZ.md)


# Winning Health Technology Group Co.,Ltd. (300253.SZ)

## Company Overview

Winning Health Technology Group Co., Ltd., together with its subsidiaries, provides digital health services for medical and health institutions in China. The company offers WiNEX, a digital health platform; internet and health care; smart hospital; smart regional healthcare; and WinCloud solutions. Its solutions are used in smart hospitals, regional health, primary health, medical insurance, health services, and other fields. The company is involved in general projects; software development; information system integration, operation, and maintenance; investment; leasing of non-residential real estate properties; technology development, transfer, and promotion; and medical device production, operation, and sale.

| Item | Detail |
|------|--------|
| Industry | Health Care Technology |
| Exchange | CN Market |
| Website | [www.winning.com.cn](https://www.winning.com.cn) |

## Key Drivers
> *AI-analyzed key factors driving this stock's performance*


## Longbridge Financial Score™: D
> *Longbridge Financial Score™ — Proprietary multi-factor rating model by Longbridge*
> Updated: 2026-03-13T04:30:13.000Z

**Overall: D (0.69)**

**Industry**: Health Care Technology

| Metric | Value |
|--------|-------|
| Industry Ranking | 4 / 8 |
| Industry Median | D |
| Industry Average | D |

- **Style**: Value - Stocks where the company's main business is in a mature stage.
- **Scale**: Small - The company's operation has a high degree of growth and volatility, making it easy to achieve high investment returns.

**Multi Score**: D

#### Style Score Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue YoY | -31.84% |  |
| Net Profit YoY | -185.53% |  |
| P/B Ratio | 3.73 |  |
| Dividend Ratio | 0.16% |  |

#### Size Score Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Market Cap | 21033943654.56 |  |
| Revenue | 2165610015.46 |  |

#### Multi Score Score: D

| Indicator | Value | Rating |
|-----------|-------|--------|
| ROE | -5.29% | D |
| Profit Margin | -14.23% | D |
| Gross Margin | 15.59% | D |
| Revenue YoY | -31.84% | E |
| Net Profit YoY | -185.53% | E |
| Total Assets YoY | -2.65% | D |
| Net Assets YoY | -2.78% | D |
| Cash Flow Margin | -702.55% | E |
| OCF YoY | -31.84% | E |
| Turnover | 0.26 | D |
| Gearing Ratio | 31.31% | B |

```chart-data:radar
{
  "title": "Longbridge Financial Score - Winning Health Technology Group Co.,Ltd.",
  "chart_type": "radar",
  "dimensions": [
    {
      "name": "Style Score",
      "grade": "",
      "indicators": [
        {
          "name": "Revenue YoY",
          "value": "-31.84%",
          "rating": ""
        },
        {
          "name": "Net Profit YoY",
          "value": "-185.53%",
          "rating": ""
        },
        {
          "name": "P/B Ratio",
          "value": "3.73",
          "rating": ""
        },
        {
          "name": "Dividend Ratio",
          "value": "0.16%",
          "rating": ""
        }
      ]
    },
    {
      "name": "Size Score",
      "grade": "",
      "indicators": [
        {
          "name": "Market Cap",
          "value": "21033943654.56",
          "rating": ""
        },
        {
          "name": "Revenue",
          "value": "2165610015.46",
          "rating": ""
        }
      ]
    },
    {
      "name": "Multi Score",
      "grade": "D",
      "indicators": [
        {
          "name": "ROE",
          "value": "-5.29%",
          "rating": "D"
        },
        {
          "name": "Profit Margin",
          "value": "-14.23%",
          "rating": "D"
        },
        {
          "name": "Gross Margin",
          "value": "15.59%",
          "rating": "D"
        },
        {
          "name": "Revenue YoY",
          "value": "-31.84%",
          "rating": "E"
        },
        {
          "name": "Net Profit YoY",
          "value": "-185.53%",
          "rating": "E"
        },
        {
          "name": "Total Assets YoY",
          "value": "-2.65%",
          "rating": "D"
        },
        {
          "name": "Net Assets YoY",
          "value": "-2.78%",
          "rating": "D"
        },
        {
          "name": "Cash Flow Margin",
          "value": "-702.55%",
          "rating": "E"
        },
        {
          "name": "OCF YoY",
          "value": "-31.84%",
          "rating": "E"
        },
        {
          "name": "Turnover",
          "value": "0.26",
          "rating": "D"
        },
        {
          "name": "Gearing Ratio",
          "value": "31.31%",
          "rating": "B"
        }
      ]
    }
  ]
}
```

## Valuation Analysis

| Metric | Current | Industry Ranking | High | Median | Low |
|--------|---------|-----------------|------|--------|-----|
| PE (TTM) | -68.24 | 7/8 | 303.05 | 284.56 | 72.37 |
| PB | 3.73 | 5/8 | 4.15 | 3.69 | 3.44 |
| PS (TTM) | 9.71 | 5/8 | 9.46 | 8.61 | 8.08 |
| Dividend Yield | 0.16% | 2/8 | 0.18% | 0.16% | 0.14% |

## Peer Comparison

| Rank | Name | Profit | Growth | Operation | Security | Cash | Rating |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 01 | Heren Health (300550.SZ) | B | C | D | B | C | C |
| 02 | Yarward (301337.SZ) | D | D | D | A | D | C |
| 03 | VANFUND (000638.SZ) | D | B | A | C | C | C |
| 04 | Winning Health (300253.SZ) | D | E | D | B | E | D |
| 05 | B-Soft (300451.SZ) | D | E | D | B | E | D |

## Institutional View

### Analyst Rating Distribution

> As of 2026-02-13T16:00:00.000Z

Total Analysts: **2**

| Rating | Count | Percentage |
|--------|-------|-----------| 
| Buy | 1 | 50% |
| Overweight | 1 | 50% |

### Target Price Forecast

| Metric | Price |
|--------|-------|
| Current Price | 9.21 |
| Highest Target | 10.46 |
| Lowest Target | 10.20 |

## References

- [Company Overview — Profile, executives, shareholders, business breakdown](https://longbridge.com/en/quote/300253.SZ/overview.md)
- [Financial Reports — Income, balance sheet, cash flow, dividends](https://longbridge.com/en/quote/300253.SZ/norm.md)
- [Related News](https://longbridge.com/en/quote/300253.SZ/news.md)
- [Filings — Company announcements and regulatory filings](https://longbridge.com/en/quote/300253.SZ/filings.md)

---

> **Disclaimer: This article is for reference only and does not constitute any investment advice.**